CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Ceftriaxone Injection via the Deltoid for the Treatment for Gonorrhea: Clinical Effectiveness and Guidelines

Last updated: October 24, 2017
Project Number: RB1148-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness for the injection of ceftriaxone sodium (rocephin) in the deltoid?
  2. What are the evidence-based guidelines on the injection of ceftriaxone sodium (rocephin) in the deltoid?

Key Message

No relevant literature was identified regarding the injection of ceftriaxone sodium (rocephin) in the deltoid.